Critical care lessons from severe acute respiratory syndrome

Current Opinion in Critical Care

Volumn 10, Issue 1, 2004, Pages 53-58

  Lapinsky, Stephen E ^a,c   Granton, John T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c NONE   (Canada)

Author keywords

Acute respiratory distress syndrome; Atypical pneumonia; Severe acute respiratory syndrome; Viral pneumonia

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERFERON; LOPINAVIR; MACROLIDE; METHYLPREDNISOLONE; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; RITONAVIR;

CANADA; CHINA; CLINICAL FEATURE; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG MEGADOSE; EPIDEMIC; GENE SEQUENCE; HEALTH CARE PERSONNEL; HEMOLYTIC ANEMIA; HONG KONG; HUMAN; INFECTION CONTROL; INTENSIVE CARE; LUNG INFILTRATE; MEDICAL PRACTICE; MORTALITY; PATHOGENESIS; PATIENT CARE; PHYSICIAN; PROGNOSIS; RADIOLOGY; RESPIRATORY FAILURE; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; SINGAPORE; TERATOGENESIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADRENAL CORTEX HORMONES; ANTIVIRAL AGENTS; CHINA; HONG KONG; HUMANS; INFECTION CONTROL; INTENSIVE CARE; ONTARIO; PROGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SINGAPORE; TREATMENT OUTCOME;

EID: 0842269733     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200402000-00009     Document Type: Review

References (36)

1. World Health Organization: Severe acute respiratory syndrome (SARS): status of the outbreak and lessons for the immediate future. CSR/WHO May 2003. Available at http://www.who.int/csr/media/sars_wha.pdf Accessed September 5th 2003
2. Tsang KW, Ho PL, Ooi GC, et al.: A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003, 348:1977-1985. One of two papers published simultaneously providing the first description of SARS. This paper from Hong Kong reviews 10 cases of SARS.
3. Poutanen SM, Low DE, Henry B, et al.: Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003, 348:1995-2005. This is one of two initial publications describing SARS, reviewing the initial 10 cases from Toronto, and suggesting an etiologic role of the coronavirus.
4. Lee N, Hui D, Wu A, et al.: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003, 348:1986-1994. A detailed description of the clinical characteristics of 138 patients with SARS from Hong Kong.
5. World Health Organization: Summary table of SARS cases by country, 1 November 2002-7 August 2003. http://www.who.int/csr/sars/ country/2003_08_15/en/ . Accessed September 4th, 2003.
6. Ksiazek TG, Erdman D, Goldsmith CS, et al.: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348:1953-1966. This is one of two papers identifying a novel coronavirus from clinical specimens of patients with SARS and demonstrating a lack of antibodies in a sample of control subjects from the United States.
7. Drosten C, Gunther S, Preiser W, et al.: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348:1967-1976. This is one of two initial publications identifying a novel coronavirus from clinical specimens of SARS patients
8. Peiris JS, Lai ST, Poon LL, et al.: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361:1319-1325. This study analyzed 50 patients with a clinical diagnosis of SARS and demonstrated evidence of infection with a novel coronavirus in clinical specimens of 45 patients.
9. Kuiken T, Fouchier RA, Schutten M, et al.: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003, 362:263-270. An important study confirming SARS-CoV as the etiologic agent of SARS, by demonstrating the virus in clinical specimens and producing a SARS-syndrome in animals by inoculation of the virus.
10. Marra MA, Jones SJ, Astell CR, et al.: The genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-1404. This is the first description of the full gene sequence of the newly identified SARS-CoV, demonstrating that this virus does not resemble previously described coronaviruses.
11. Severe acute respiratory syndrome: Singapore, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:405-411
12. Riley S, Fraser C, Donnelly CA, et al.: Transmission dynamics of the etiological agent. Science 2003, 300:1961-1966. This analysis of the first 10 weeks of the SARS outbreak in Hong Kong identifies the SARS-CoV as being moderately transmissible, with occasional "super-spreaders".
13. Peiris JSM, Chu CM, Cheng VCC, et al.: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772. A very valuable study from Hong Kong that prospectively followed 75 patients for 3 weeks, describing the pattern of viral shedding, usefulness of viral testing, and prognostic factors for poor outcome.
14. World Health Organization: First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Available at: http://www.who.int/csr/sars/survival_2003_05_04/en/index.html Accessed September 4th, 2003.
15. Cluster of severe acute respiratory syndrome cases among protected healthcare workers: Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep 2003, 52:433-436.
16. World Health Organization: WHO case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www. who.int/csr/sars/casedefinition/en/. Accessed April 20, 2003.
17. Rainer TH, Cameron PA, Smit D, et al.: Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ 2003, 326:1354-1358.
18. World Health Organization: Use of laboratory tests for SARS diagnosis. Available at: http://www.who.int/csr/sars/labmethods/en/ Accessed September 4th, 2003.
19. Booth CM, Matukas LM, Tomlinson GA, et al.: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801-2809. The Toronto group provide a detailed review of 144 patients with SARS, in terms of the clinical features, diagnostic criteria, disease course, management, and factors affecting outcome.
20. Tsui PT, Kwok ML, Yuen H, Lai ST: Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerging Infect Dis 2003, 9:1064-1069. This large retrospective analysis of 323 patients from Hong Kong characterizes the clinical course and identifies pretreatment prognostic factors.
21. Fowler RA, Lapinsky SE, Hallett D, et al.: Critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:367-373. The Toronto group characterize the clinical features and course of 39 critically ill patients with SARS and the effect of the outbreak on critical resources in the city.
22. Lew TWK, Kwek TK, Tai D, et al.: Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003, 290:374-380. This study from Singapore describes the ICU course of 46 critically ill patients with SARS, including ventilatory parameters, complications, and outcome.
23. Wong KT, Antonio GE, Hui DS, et al.: Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003, 228:401-406. This paper describes the chest radiographic appearance and evolution in 138 patients with SARS.
24. Grinblat L, Shulman H, Glickman A, et al.: Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology 2003, 228:802-809. This study evaluated the chest radiographic progression of 40 patients with SARS.
25. Wong KT, Antonio GE, Hui DS, et al.: Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology 2003, 228:395-400. The first detailed description of the computed tomographic appearance of SARS, based on findings in 74 patients.
26. So LK, Lau ACW, Yam LYC, et al.: Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003, 361:1615-1617. This paper from Hong Kong, published early in the SARS outbreak, provided valuable information on treatment options and suggested an effective treatment protocol.
27. Ho JC, Ooi GC, Mok TY, et al.: High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003. One of the first studies to compare treatment options in SARS, this paper demonstrates that high-dose pulse corticosteroids are as safe as and probably more effective than lower dose regimens.
28. Zhao Z, Zhang F, Xu M, et al.: Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003, 52:715-720. This study of 190 patients from China compares the clinical response to four different treatment regimens, demonstrating a benefit of early administration of high-dose corticosteroids.
29. Sung J: Clinical diagnosis and management of SARS. WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/ csr/sars/conference/june_2003/materials/presentations/ en/clinical_diagnosis. pdf Accessed Sept 4th, 2003.
30. Wong VWS, Dai D, Wu AKL, Sung JJY: Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003, 9:199-201.
31. Cinatl J, Morgenstern B, Bauer G, et al.: Treatment of SARS with human interferons. Lancet 2003, 362:293-294.
32. Lapinsky SE, Hawryluck L: ICU management of severe acute respiratory syndrome. Intensive Care Med 2003, 29:870-875. This review presents an overview of the clinical features and management of critically ill patients with SARS.
33. Franks TJ, Chong PY, Chui P, et al.: Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore. Hum Pathol 2003, 34:729.
34. Nicholls JM, Poon LL, Lee KC, et al.: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003, 361:1773-1778.
35. Mazzulli T, Farcas GA, Poutanen SM, et al.: Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004. Available from www.cdc.gov/ncidod/EID/vol10no1/03-0404.htm
36. Seto WH, Tsang D, Yung RW, et al.: Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003, 361:1519-1520. This case-control study from five hospitals in Hong Kong identified droplet spread as the predominant mechanism for disease transmission.